New Drug Is First to Help Patients With Recurrent Low-Grade Ovarian Cancer Science Daily (press release) Cancer-causing genetic mutations in BRAF and KRAS genes occur more frequently in low-grade ovarian cancer, so the researchers chose a drug that...

Via Brian Shields